Francesco Bergami, PhD

Francesco Bergami, PhD has been working in the pharmaceutical industry since 2018. Francesco is currently a Project Manager at DOMAIN Therapeutics, where they are responsible for a drug development program. Francesco'sduties include R&D development of small molecules and biologics, biomarker identification and validation, target identification and validation, lead asset optimization, validation of drug candidate, daily interaction with CRO and service providers, scientific and business intelligence, planning and budget management, and strategy development. Prior to this role, they were a Junior Strategy Manager at the Centre européen d'étude du Diabète - CeeD in 2017. Before that, they were a PhD Student at the CNRS from 2013 to 2017, where they validated candidate genes identified by mass spectrometry and studied the cellular biology of the antiviral immunity in insects.

Francesco Bergami, PhD obtained their Master's degree from Alma Mater Studiorum - Università di Bologna in 2010-2013 in the field of Pharmaceutical Biotechnology. Francesco then went on to obtain their Doctor of Philosophy - PhD from Ecole Doctorale des Sciences de la Vie et de la Santé - Strasbourg in 2013-2017 in the field of Virology. Finally, in 2017-2018 they obtained their Master of Business Administration - MBA from Faculté des Sciences Economiques et de Gestion de Strasbourg (FSEG) in the field of Project Management of Innovation (Ingénierie de projets innovants - IPI).